Vaccine News and Research

Latest Vaccine News and Research

Study shows emerging Omicron sublineages efficiently evade neutralization independent of immunization history

Study shows emerging Omicron sublineages efficiently evade neutralization independent of immunization history

12 Dec 2022
Reports of Mpox disease following recent vaccination

Reports of Mpox disease following recent vaccination

11 Dec 2022
Intranasal recombinant MVA-based vaccines effective against SARS-CoV-2 variants in mice

Intranasal recombinant MVA-based vaccines effective against SARS-CoV-2 variants in mice

11 Dec 2022
How convergent evolution is creating new COVID-19 waves

How convergent evolution is creating new COVID-19 waves

11 Dec 2022
Researchers seek to reduce Chikungunya virus-caused joint pain with new drug

Researchers seek to reduce Chikungunya virus-caused joint pain with new drug

9 Dec 2022
WashU’s nasal COVID-19 vaccine authorized for emergency use in India as a booster

WashU’s nasal COVID-19 vaccine authorized for emergency use in India as a booster

9 Dec 2022
HIV-positive people are protected by Covid vaccines

HIV-positive people are protected by Covid vaccines

9 Dec 2022
People show prejudice, discriminatory attitudes towards unvaccinated individuals during the pandemic

People show prejudice, discriminatory attitudes towards unvaccinated individuals during the pandemic

8 Dec 2022
Multi-stage HIV vaccine regimen shows promising results in Phase 1 clinical trial

Multi-stage HIV vaccine regimen shows promising results in Phase 1 clinical trial

8 Dec 2022
COVID-19 vaccines may reduce long-COVID symptoms

COVID-19 vaccines may reduce long-COVID symptoms

8 Dec 2022
The Native Antigen Company expands infectious disease portfolio to include Sudan Ebolavirus Boniface 1976 Glycoprotein

The Native Antigen Company expands infectious disease portfolio to include Sudan Ebolavirus Boniface 1976 Glycoprotein

From The Native Antigen Company 8 Dec 2022
Exploring a variant-adapted SARS-CoV-2 recombinant protein vaccine

Exploring a variant-adapted SARS-CoV-2 recombinant protein vaccine

8 Dec 2022
Exploring COVID-19 vaccination prioritization strategies for primary and booster doses

Exploring COVID-19 vaccination prioritization strategies for primary and booster doses

8 Dec 2022
Booster COVID-19 mRNA vaccinations marginally increase the durability of neutralizing antibody responses

Booster COVID-19 mRNA vaccinations marginally increase the durability of neutralizing antibody responses

8 Dec 2022
Whole genome sequencing helps construct the first blood virological profile of Chinese population

Whole genome sequencing helps construct the first blood virological profile of Chinese population

7 Dec 2022
Scientists report the in vitro production of infectious Plasmodium falciparum sporozoites

Scientists report the in vitro production of infectious Plasmodium falciparum sporozoites

7 Dec 2022
Scientists develop new receptor “decoy” drug that potently neutralizes SARS-CoV-2 variants

Scientists develop new receptor “decoy” drug that potently neutralizes SARS-CoV-2 variants

7 Dec 2022
Vaccination against E. coli could help prevent some forms of childhood malnutrition, stunting

Vaccination against E. coli could help prevent some forms of childhood malnutrition, stunting

7 Dec 2022
UK's Newton Fund supported Mexican scientist to develop vaccines against Chikungunya, Zika and Dengue

UK's Newton Fund supported Mexican scientist to develop vaccines against Chikungunya, Zika and Dengue

7 Dec 2022
Cancer immunotherapies can become more potent depending on the time of day

Cancer immunotherapies can become more potent depending on the time of day

7 Dec 2022

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback